Health ❯ Healthcare ❯ Patient Outcomes ❯ Survival Rates

Disease-Free Survival

ctDNA-Guided Atezolizumab Extends Survival After Bladder Cancer Surgery in Phase III Trial

Regulators will now evaluate linking immunotherapy use to a ctDNA companion test.